Wall Street Analysts See a 57.56% Upside in Arcus Biosciences (RCUS): Can the Stock Really Move This High?

Shares of Arcus Biosciences, Inc. (RCUS) have gained 1.2% over the past four weeks to close the last trading session at $21.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $34.6 indicates a potential upside of 57.6%.The average comprises 10 short-term price targets ranging from a low of $20.00 to a high of $52.00, with a standard deviation of $10.17. While the lowest estimat ...